Fisher & Paykel Healthcare Corporation Limited Share Price

Equities

FPH

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

End-of-day quote New Zealand S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
27.4 NZD -1.69% Intraday chart for Fisher & Paykel Healthcare Corporation Limited +3.01% +16.10%

Financials

Sales 2024 * 1.73B 1.03B 85.79B Sales 2025 * 1.94B 1.15B 96.16B Capitalization 16B 9.5B 792B
Net income 2024 * 256M 152M 12.67B Net income 2025 * 332M 197M 16.44B EV / Sales 2024 * 9.34 x
Net Debt 2024 * 179M 107M 8.88B Net Debt 2025 * 235M 139M 11.63B EV / Sales 2025 * 8.36 x
P/E ratio 2024 *
62.1 x
P/E ratio 2025 *
47.8 x
Employees 6,420
Yield 2024 *
1.44%
Yield 2025 *
1.56%
Free-Float 91.12%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Fisher & Paykel Healthcare Corporation Limited

1 day-1.69%
1 week+3.01%
Current month+6.82%
1 month+3.59%
3 months+14.41%
6 months+32.37%
Current year+16.10%
More quotes
1 week
26.21
Extreme 26.21
28.50
1 month
25.00
Extreme 25
28.50
Current year
22.55
Extreme 22.55
28.50
1 year
20.29
Extreme 20.29
28.50
3 years
18.02
Extreme 18.02
36.55
5 years
14.85
Extreme 14.85
37.89
10 years
3.95
Extreme 3.95
37.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 01/85/01
Director of Finance/CFO - 01/19/01
Chief Tech/Sci/R&D Officer - 01/07/01
Members of the board TitleAgeSince
Director/Board Member 66 01/90/01
Chairman - 01/15/01
Chief Executive Officer 63 01/85/01
More insiders
Date Price Change Volume
26/24/26 27.4 -1.69% 888,040
24/24/24 27.87 +5.01% 488,738
23/24/23 26.54 +0.38% 396,775
22/24/22 26.44 -0.60% 362,331
19/24/19 26.6 +0.23% 1,330,528

End-of-day quote New Zealand S.E., April 26, 2024

More quotes
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.
Calendar
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
27.4 NZD
Average target price
24.13 NZD
Spread / Average Target
-11.93%
Consensus